<p>Abbreviations: CI, confidence interval; HDL, high density lipoprotein; LDL, low density lipoprotein; SD, standard deviation; VLDL, very low density lipoprotein.</p>a<p>The P-values shown are for the between-group comparisons of % changes from baseline to the primary efficacy timepoint. P-values are obtained by the t-test for all parameters except LDL/HDL Ratio, where the Wilcoxon rank-sum test was used due to deviations from normality.</p>b<p>Baseline and primary efficacy timepoint values are expressed as median (interquartile range); percent change is presented as median (interquartile range).</p
<p>Values are means ±SEM. Continuous variables were compared using the analysis of variance (ANOVA)....
<p>A: patients with normal baseline values. B: patients with abnormal baseline values on previous NN...
<p><b>Copyright information:</b></p><p>Taken from "Optimal Lipid Modification: The Rationale for Com...
<p>Values are presented as medians (IQR).</p><p>Abbreviations: HDL, high-density lipoprotein; LDL, l...
<p>Data are presented as median (interquartile range -IQR).</p><p>Abbreviations: LDL, low-density li...
<p>*P value from paired samples t-test, comparing baseline and follow-up measurements in each treatm...
<p>Data are presented as mean ± SD and in the case of triglycerides as medians (interquartile range)...
Lipid-lowering therapies have been shown to improve cardiovascular outcome in a wide range of patien...
<p>Data are expressed as mean ± standard deviation, median (25 percentile, 75 percentile) or number ...
*<p>Data are means (SDs) or numbers (%) in participants with at least one adiponectin measurement av...
<p>Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein. Data are expressed as...
<p>*indicate significant differences (P-value<0.05). All are between group comparisons.</p><p>LDL: L...
<p>On-study and change from baseline plasma lipoprotein subfraction concentrations (95% confidence i...
<p>Subjects were divided approximately in tertiles: baseline PCSK9<40 ng/mL, 40 to <60 ng/mL, or ≥60...
<p>Values are expressed as mean ± SD, median with interquartile range or n (%).</p><p>LDL-C = low-...
<p>Values are means ±SEM. Continuous variables were compared using the analysis of variance (ANOVA)....
<p>A: patients with normal baseline values. B: patients with abnormal baseline values on previous NN...
<p><b>Copyright information:</b></p><p>Taken from "Optimal Lipid Modification: The Rationale for Com...
<p>Values are presented as medians (IQR).</p><p>Abbreviations: HDL, high-density lipoprotein; LDL, l...
<p>Data are presented as median (interquartile range -IQR).</p><p>Abbreviations: LDL, low-density li...
<p>*P value from paired samples t-test, comparing baseline and follow-up measurements in each treatm...
<p>Data are presented as mean ± SD and in the case of triglycerides as medians (interquartile range)...
Lipid-lowering therapies have been shown to improve cardiovascular outcome in a wide range of patien...
<p>Data are expressed as mean ± standard deviation, median (25 percentile, 75 percentile) or number ...
*<p>Data are means (SDs) or numbers (%) in participants with at least one adiponectin measurement av...
<p>Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein. Data are expressed as...
<p>*indicate significant differences (P-value<0.05). All are between group comparisons.</p><p>LDL: L...
<p>On-study and change from baseline plasma lipoprotein subfraction concentrations (95% confidence i...
<p>Subjects were divided approximately in tertiles: baseline PCSK9<40 ng/mL, 40 to <60 ng/mL, or ≥60...
<p>Values are expressed as mean ± SD, median with interquartile range or n (%).</p><p>LDL-C = low-...
<p>Values are means ±SEM. Continuous variables were compared using the analysis of variance (ANOVA)....
<p>A: patients with normal baseline values. B: patients with abnormal baseline values on previous NN...
<p><b>Copyright information:</b></p><p>Taken from "Optimal Lipid Modification: The Rationale for Com...